Abstract:Background: Very early-onset inflammatory bowel disease (VEO-IBD) occurs in young children and causes severe clinical manifestations which have poor responses to traditional IBD treatments. At present, there are no simple and reliable laboratory indicators for early screening VEO-IBD patients especially those who were caused by monogenic diseases. Methods: A retrospective analysis was performed in 73 patients with VEO-IBD admitted to our hospital in the past 5 years. Based on the next-generation sequencing results they were divided into monogenic IBD group (M-IBD) and non-monogenic IBD group (NM-IBD). Forty age-matched patients with allergic proctocolitis were the control group (food allergy, FA). Evaluating the clinical manifestations and the inflammatory factors in peripheral blood. The logistic regression analysis and receiver operating characteristic (ROC) curve analysis were used to find the screening factors and cut-off values of VEO-IBD as well as monogenic VEO-IBD, respectively. Findings: Among the 73 VEO-IBD patients, 44 cases were in the M-IBD group, 35 of whom carried IL-10RA mutations, and the most common mutations were c.301C>T (p.R101W, 30/70) and the c.537G>A (p.T179T, 17/70). The higher the serum TNF-α value was, the greater the risk of diagnosing IBD (OR=1·25, 95%CI: 1·05, 1·50, P=0·013) and the higher serum albumin level meant it was less likely to have IBD (OR= 0·86, 95%CI: 0·74, 1·00, P=0·048). ROC analysis showed that the cut-off values of TNF-α and albumin were 17·40 pg/mL ( sensitivity: 0·78, specificity: 0·88 ) and 36·50 g/L (sensitivity: 0·80, specificity: 0·90), respectively. The increased ferritin level was indicative of a genetic mutation in VEO-IBD patients. Its cut-off value was 28·20 ng/mL (sensitivity: 0·93, specificity: 0·92). Moreover, when IL-10 level was higher than 33·05 pg/ml (sensitivity: 1·00, specificity: 0·84), or the onset age was earlier than 0·21 months (sensitivity: 0·82, specificity: 0·94), it was strongly suggested the presence of disease-causing mutations in IL-10RA in VEO-IBD patients. Interpretation: A high proportion of Mendelian disease was present in VEO-IBD patients, of which IL-10RA was the most common disease-causing gene. Serum TNF-α and albumin level could be used for differentiating VEO-IBD patients from children with allergic proctocolitis, as well as serum ferritin and IL-10 may serve as early screening indicators for monogenic VEO-IBD, thereby shortening the time for disease diagnosis. Funding: This study was funded by Scientific researching fund of Shanghai Municipal Health Commission(No·201640368) and National Natural Science Foundation of China Grant (No·81741103).Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: This study was approved by the ethics committee of Ruijin Hospital, Shanghai Jiaotong University, School of Medicine. All guardians of the enrolled pediatric patients who experienced the gene test signed an informed consent form.

P071 Neonatal levels of inflammatory markers in individuals who later develop early onset Inflammatory Bowel Disease

P1090 Exposure to an inflammatory prenatal environment and the risk of Inflammatory Bowel Disease in the offspring: a population-based cohort study

Maternal Inflammatory Bowel Disease During Pregnancy and Infectious Disease in Offspring Younger Than 5 Years: A Population-Based Cohort Study.

Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study

OP02 The breastmilk proteomics of women with Inflammatory Bowel Disease (IBD) and its impact on fecal calprotectin and microbiota composition in their babies

Placental Histopathological Lesions and Adverse Neonatal Outcomes in Patients with Inflammatory Bowel Diseases- A retrospective Cohort Study

Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age

DOP20 Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel Disease

Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study

The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn

Factors associated with neurodevelopment in preterm infants with systematic inflammation

Early-Life Diet Diversity and the Subsequent Risk of Inflammatory Bowel Disease: Findings From Two Scandinavian Birth Cohorts

P1168 Anthropometric trajectories prior to the development of inflammatory bowel disease in Danish school-aged children and adolescents from 1997 to 2017

Placental and intra-amniotic inflammation are associated with altered fetal immune responses at birth

A Retrospective Study of 73 Chinese Children with Very Early Onset Inflammatory Bowel Disease (VEO-IBD): Searching for Laboratory Indicators for Early Screening of Patients with Monogenic VEO-IBD

Intrauterine Inflammation Exposure May Increase the Risk of Late-Onset Sepsis in Premature Infants:A Retrospective Cohort Study

The intestinal microbiome of inflammatory bowel disease across the pediatric age range

A Study on the Interleukin-10 Receptor Gene Mutations and Neonatal Very Early Onset Inflammatory Bowel Disease in 5 Infants

Early Life Modifiable Exposures and Their Association With Owner Reported Inflammatory Bowel Disease Symptoms in Adult Dogs

Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning

The Role of Maternal and Early-Life Diet in Inflammatory Bowel Disease